By marrying pharmacology with behavior change, we can resolve the adherence dilemma that has plagued real-world use of these drugs
The transaction is expected to close in the second quarter of 2025
doi: 10.1053/j.gastro.2022.12.007 55 TrikudanathanGFeussomGTeigenLMunigalaSPriceKDirweeshAet al
It is one of the body's most important endogenous antioxidants, naturally produced in every cell, with particularly high concentrations in the liver
10.1074/jbc.M805517200 509 Johnson J
11 were in the final stages of clinical trials as of June 2024 [114] Among others, Hangzhou Jiuyuan Gene Engineering, The United Laboratories, CSPC Pharmaceutical Group, Huadong Medicine (which also holds a majority stake in Jiuyuan Gene [117] ) and Sihuan Pharmaceutical were all preparing generic offerings